PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization
Research output: Contribution to journal › Article › peer-review
85Citations
(Scopus)
Fingerprint
Dive into the research topics of 'PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organization'. Together they form a unique fingerprint.